Immunotherapy Demonstrates Early Promise Across Lymphoma Subgroups – OncLive
OncLive |
Immunotherapy Demonstrates Early Promise Across Lymphoma Subgroups
OncLive During the 2017 OncLive® State of the Science Summit on Hematologic Malignancies, Stephen M. Ansell, MD, PhD, chair of the Lymphoma Group at Mayo Clinic, lectured on the state of immunotherapy in lymphoma. In an interview, he shared insight on the … |
